Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Windler

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Deutsche Medizinische Wochenschrift (1946)|January 19, 1996
[Should lipid-lowering agents be prescribed in myasthenia?]E Windler
Der Internist|October 27, 2004
[Cardiovascular risk in the "Women's Health Initiative". Much ado about nothing?]E Windler
Advances in Experimental Medicine and Biology|January 1, 1987
The uptake of chylomicron remnants by the liverE E Windler
Der Internist|December 23, 2003
[Pravastatin for older patients with risk of vascular disease. The PROSPER-Study]E Windler, H Greten
Deutsche Medizinische Wochenschrift (1946)|January 25, 1991
[The diagnosis of lipid metabolic disorders]E Windler, H Greten
Deutsche Medizinische Wochenschrift (1946)|January 29, 1988
[Can and should we manipulate our LDL receptors?]E Windler, H Greten
Der Internist|August 22, 2013
[Statin therapy and cancer-related mortality]E Windler, S Nitschmann
Deutsche Medizinische Wochenschrift (1946)|February 1, 1991
[The therapy of lipid metabolic disorders]E Windler, H Greten
Hormone and Metabolic Research. Supplement Series|January 1, 1988
Regulation of the intravascular pathways of intestinal lipidsE Windler, H Greten
Der Internist|December 1, 1993
[HMG-CoA reductase inhibitors in therapy of disorders of lipid metabolism]E Windler, H Greten
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Deutsche Medizinische Wochenschrift (1946)|January 19, 1996
[Should lipid-lowering agents be prescribed in myasthenia?]E Windler
Der Internist|October 27, 2004
[Cardiovascular risk in the "Women's Health Initiative". Much ado about nothing?]E Windler
Advances in Experimental Medicine and Biology|January 1, 1987
The uptake of chylomicron remnants by the liverE E Windler
Der Internist|December 23, 2003
[Pravastatin for older patients with risk of vascular disease. The PROSPER-Study]E Windler, H Greten
Deutsche Medizinische Wochenschrift (1946)|January 25, 1991
[The diagnosis of lipid metabolic disorders]E Windler, H Greten
Deutsche Medizinische Wochenschrift (1946)|January 29, 1988
[Can and should we manipulate our LDL receptors?]E Windler, H Greten
Der Internist|August 22, 2013
[Statin therapy and cancer-related mortality]E Windler, S Nitschmann
Deutsche Medizinische Wochenschrift (1946)|February 1, 1991
[The therapy of lipid metabolic disorders]E Windler, H Greten
Hormone and Metabolic Research. Supplement Series|January 1, 1988
Regulation of the intravascular pathways of intestinal lipidsE Windler, H Greten
Der Internist|December 1, 1993
[HMG-CoA reductase inhibitors in therapy of disorders of lipid metabolism]E Windler, H Greten
Pageof 11